Sequencing Options Expand for Patients With HER2+ MBC and Brain Metastases
June 5th 2020Collectively, there are more options than ever in the space of HER2-positive breast cancer brain metastases, a significant advance for our hundreds and thousands of patients facing this challenging disease.
Read More